Cargando…
An MCEM Framework for Drug Safety Signal Detection and Combination from Heterogeneous Real World Evidence
Delayed drug safety insights can impact patients, pharmaceutical companies, and the whole society. Post-market drug safety surveillance plays a critical role in providing drug safety insights, where real world evidence such as spontaneous reporting systems (SRS) and a series of disproportional analy...
Autores principales: | Xiao, Cao, Li, Ying, Baytas, Inci M., Zhou, Jiayu, Wang, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789130/ https://www.ncbi.nlm.nih.gov/pubmed/29379048 http://dx.doi.org/10.1038/s41598-018-19979-7 |
Ejemplares similares
-
Stochastic convex sparse principal component analysis
por: Baytas, Inci M., et al.
Publicado: (2016) -
Real-world evidence in antiretroviral therapy: drug safety data
por: Silva, Ana-Marta, et al.
Publicado: (2020) -
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
por: Chan, Kelvin, et al.
Publicado: (2020) -
The real-world impact of National Institute for Health and Care Excellence's real-world evidence framework
por: Duffield, Stephen, et al.
Publicado: (2023) -
Multi-cue temporal modeling for skeleton-based sign language recognition
por: Özdemir, Oğulcan, et al.
Publicado: (2023)